CA
THC icon

Claris Advisors’s Tenet Healthcare THC Stock Holding History

Claris Advisors’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6
Closed -$997 – 1041
2024
Q3 		$997 Buy
+6
New +$907 ﹤0.01% 436

Other funds holding THC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Claris Advisors's THC Position: Q4 2024 in Review

Claris Advisors sold out of Tenet Healthcare (THC) in Q4 2024, closing a stake of 6 shares — an estimated $997 sold.

Claris Advisors first reported a position in THC in Q3 2024 and held it in 1 quarter. The position peaked at $997 in Q3 2024. 577 funds tracked by Wall St. Rank hold THC as of Q4 2024.

  • Claris Advisors reported no remaining Tenet Healthcare position as of Q4 2024 after selling out during the quarter.
  • Claris Advisors sold 6 Tenet Healthcare shares in Q4 2024, an estimated $997.
  • Claris Advisors first reported a position in Tenet Healthcare in Q3 2024 and held it in 1 quarter.
  • Claris Advisors's Tenet Healthcare position peaked at $997 in Q3 2024.
  • 577 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2024.

Based on Claris Advisors's 13F filing for Q4 2024, filed 7 Feb 2025.